SCHEMBL5387967

SCHEMBL5387967

Nc1ccc(OCC(O)C=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.45
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
ADRB3 P13945 1/20 0.44
TDP1 Q9NUW8 3/20 0.44
TSHR P16473 2/20 0.44
MAPT P10636 3/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 1/20 0.39
MAOB P27338 2/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 1/20 0.39
MAOA P21397 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.38
CA1 P00915 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23838042 0.81 MAPT (0.47) TDP1TSHRMAPTLMNAPOLB
SCHEMBL13399502 0.81 NPC1 (0.46) TSHRMAPTLMNAPOLBNPSR1
SCHEMBL4212363 0.81 LMNA (0.57) ADRB2ADRB1ADRB3TSHRMAPT
SCHEMBL6141129 0.78 TDP1 (0.52) APPADRB2ADRB1ADRB3TDP1
SCHEMBL7934862 0.78 MAPT (0.55) APPADRB2ADRB1ADRB3TDP1
SCHEMBL4410827 0.77 HIF1A (0.55) TDP1TSHRMAPTLMNAPOLB
SCHEMBL8479002 0.75 TDP1 (0.48) APPADRB2ADRB1ADRB3TDP1
SCHEMBL6912197 0.75 LMNA (0.64) APPADRB2ADRB1ADRB3TDP1
SCHEMBL23827362 0.74 TDP1 (0.44) APPADRB2ADRB1ADRB3TDP1
SCHEMBL23827366 0.74 TDP1 (0.44) APPADRB2ADRB1ADRB3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4659569-A Process for the production of virus vaccine KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1987-04-21 US claimed
US-7189389-B2 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2007-03-13 US disclosed
US-20040197307-A1 Expression enhancer for protein synthesis inhibitory genes KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2004-10-07 US disclosed
US-6773701-B2 AN GENE EXPRESSION ENHANCER COMPRISING A MIXTURE OF HUMAN INTERFERON- ALPHA 2 AND INTERFERON- ALPHA 8 SUBTYPES KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2004-08-10 US disclosed
EP-1329223-A1 EXPRESSION POTENTIATOR FOR PROTEIN SYNTHESIS REGULATORY GENE Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) 2003-07-23 EP disclosed
US-20030039629-A1 Espression enhancer for protein synthesis inhibitory genes KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2003-02-27 US disclosed
US-4659569-A Process for the production of virus vaccine KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1987-04-21 US disclosed
US-4372883-A BONDING TOXIN TO POLYSACCHARIDE KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1983-02-08 US disclosed